Pathway Genomics today announced that Nature Genetics founding editor Kevin Davies, Ph.D., has joined its scientific advisory board.

“I believe Pathway is poised to make a major contribution to clinical diagnostics and improving the wellness of millions of patients. I hope to make a modest contribution to that effort.”

Kevin Davies, Ph.D.
Author of The $1,000 Genome and Cracking the Genome
Founding Editor, Nature Genetics

“I have followed Pathway closely for many years, reporting on the launch of the company in my book, The $1,000 Genome,” said Davies. “I believe Pathway is poised to make a major contribution to clinical diagnostics and improving the wellness of millions of patients. I hope to make a modest contribution to that effort.”

A highly respected science journalist, editor, and publisher with more than 20 years of experience at the forefront of advances in genetics and medicine, Davies is currently a vice president with the American Chemical Society, the largest scientific society in the world, where he serves as publisher of Chemical & Engineering News, the society’s weekly magazine. He has also served as editor-in-chief for Cell Press and was the founding editor of Bio-IT World magazine.

“Kevin is a vital thought leader in the genomics space and his work is a significant contribution to progress in the field,”

Ardy Arianpour
Chief Strategy Officer
Pathway Genomics

“Kevin is a vital thought leader in the genomics space and his work is a significant contribution to progress in the field,” said Ardy Arianpour, Pathway Genomics’ chief strategy officer. “We are exceptionally pleased to collaborate with an opinion leader of his status.”

Born in London, Davies studied biochemistry and molecular genetics at the Universities of Oxford and London before moving to the United States. He conducted postdoctoral fellowships at MIT and Harvard Medical School before moving into science publishing. Davies is the author of three popular-science books on the medical and societal implications of the genomics revolution, including Cracking the Genome and most recently The $1,000 Genome. He is a sought-after public speaker and an occasional technical consultant to the film industry, most recently serving as genetics consultant for the film Decoding Annie Parker.

Pathway Genomics’ scientific advisory board consists of leaders in various fields including oncology, pharmacogenomics, endocrinology, bioinformatics, biostatistics, behavioral genetics, nutrigenomics, and human epigenetics. To view the company’s full scientific advisory board, visit www.pathway.com.

Comments are closed.